Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease.


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
03 2019
Historique:
received: 27 03 2018
accepted: 29 06 2018
pubmed: 18 8 2018
medline: 28 10 2019
entrez: 18 8 2018
Statut: ppublish

Résumé

Because randomized coronary revascularization trials in stable coronary artery disease (CAD) have shown no reduced myocardial infarction (MI) or mortality, the threshold of quantitative myocardial perfusion severity was analyzed for association with reduced death, MI, or stroke after revascularization within 90 d after PET.

Identifiants

pubmed: 30115688
pii: jnumed.118.211953
doi: 10.2967/jnumed.118.211953
pmc: PMC6424226
doi:

Banques de données

ClinicalTrials.gov
['NCT02184117', 'NCT02328820']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

410-417

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Lancet. 2015 Nov 7;386(10006):1853-60
pubmed: 26333474
Circulation. 1994 Mar;89(3):1013-22
pubmed: 8124786
J Am Coll Cardiol. 2013 Oct 29;62(18):1639-1653
pubmed: 23954338
JACC Cardiovasc Imaging. 2017 May;10(5):565-577
pubmed: 28017383
Circulation. 2017 Dec 12;136(24):2325-2336
pubmed: 28864442
JACC Cardiovasc Imaging. 2012 Apr;5(4):430-40
pubmed: 22498334
JAMA. 2015 Oct 20;314(15):1637-8
pubmed: 26501539

Auteurs

K Lance Gould (KL)

Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas k.lance.gould@uth.tmc.edu.

Nils P Johnson (NP)

Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.

Amanda E Roby (AE)

Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.

Tung Nguyen (T)

Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.

Richard Kirkeeide (R)

Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.

Mary Haynie (M)

Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.

Dejian Lai (D)

Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center, Houston Texas.

Hongjian Zhu (H)

Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center, Houston Texas.

Monica B Patel (MB)

Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.

Richard Smalling (R)

Division of Cardiology, Department of Medicine, McGovern Medial Medical School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.

Sal Arain (S)

Division of Cardiology, Department of Medicine, McGovern Medial Medical School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.

Prakash Balan (P)

Division of Cardiology, Department of Medicine, McGovern Medial Medical School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.

Tom Nguyen (T)

Department of Cardiothoracic Vascular Surgery, McGovern Medial School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas; and.

Anthony Estrera (A)

Department of Cardiothoracic Vascular Surgery, McGovern Medial School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas; and.

Stefano Sdringola (S)

Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.

Mohammad Madjid (M)

Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.

Angelo Nascimbene (A)

Department of Advanced Cardiopulmonary Therapies and Transplantation, McGovern Medical School, University of Texas Health Science Center at Houston and Memorial Hermann Hospital, Houston, Texas.

Pranav Loyalka (P)

Department of Advanced Cardiopulmonary Therapies and Transplantation, McGovern Medical School, University of Texas Health Science Center at Houston and Memorial Hermann Hospital, Houston, Texas.

Biswajit Kar (B)

Department of Advanced Cardiopulmonary Therapies and Transplantation, McGovern Medical School, University of Texas Health Science Center at Houston and Memorial Hermann Hospital, Houston, Texas.

Igor Gregoric (I)

Department of Advanced Cardiopulmonary Therapies and Transplantation, McGovern Medical School, University of Texas Health Science Center at Houston and Memorial Hermann Hospital, Houston, Texas.

Hazem Safi (H)

Department of Cardiothoracic Vascular Surgery, McGovern Medial School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas; and.

David McPherson (D)

Division of Cardiology, Department of Medicine, McGovern Medial Medical School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH